Born April 16, New York, NY
His first bronze
Power Memorial Academy
"The #1 High School Team of The Century"
by National Sports Writers in May 2000
3 straight New York City Catholic championships
71-game winning streak
3 consecutive national championships
and Most Outstanding Player in
NBA Rookie of the Year
1st NBA Championship
6-time NBA MVP
(1971-72, 1974, 1976-77, 1980)
19th NBA All-Star Retired at age 42
Diagnosed with Philadelphia chromosome-positive
chronic myeloid leukemia (Ph+ CML) in chronic phase
Skyhook Foundation for
Continued to monitor Ph+ CML
treatment and goals
Wrote and produced documentary
"On the Shoulders of Giants"
Wrote children's book
"What Color Is My World?:
The Lost History of
Kareem's Ph+ CML treatment
journey in his own words
is an actual patient on TASIGNA® (nilotinib)
and is compensated by Novartis
Named US Global Ambassador for the Department of State
Kareem's latest bronze!
Bronze statue unveiled outside Staples Center
Kareem Abdul-Jabbar has faced many opponents on the court. But even one of basketball's most formidable all-stars can come up against an unexpected challenger. He can suddenly find himself in a game he's not sure he can win.
When Kareem started treatment for his Ph+ CML in chronic phase, he was ready to face it head on. But when it comes to cancer, things don’t always work out the way you plan. Like many people with Ph+ CML, Kareem had to work with his doctor to find the appropriate treatment for him over time. He had to take his own unique Ph+ CML journey.
IMPORTANT SAFETY INFORMATION ABOUT TASIGNA® (nilotinib) Capsules
What is the most important information to know about prescription TASIGNA?
TASIGNA can cause QT prolongation, a possible life-threatening heart problem. QT prolongation causes an irregular heartbeat, which may lead to sudden death. Call your doctor right away if you feel lightheaded, faint or have an irregular heartbeat while taking TASIGNA. These can be symptoms of QT prolongation.
Your doctor should check your heart with a test called an electrocardiogram (ECG):
Before taking TASIGNA, tell your doctor about all of your medical conditions, including if you:
It is not known if TASIGNA is safe and effective in children.
TASIGNA may cause serious side effects, including:
Common side effects
Most patients experience side effects at some time. Some common side effects you may experience include:
Tell your doctor if you have any side effect that bothers you or does not go away. These are not all of the possible side effects of TASIGNA. For more information, ask your doctor or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements.
If you need to take antacids (medicines to treat heartburn) do not take them at the same time that you take TASIGNA. If you take:
TASIGNA® (nilotinib) Indication
TASIGNA is a prescription medicine used to treat adults who have:
Please see the full prescribing information including the Boxed WARNING, and the TASIGNA Medication Guide.